Change of date: 6-month 2010 financial report on August 5, 2010

Friday, 23. July 2010 15:00
MediGene AG / Change of date: 6-month 2010 financial report on August 5, 2010 processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.

Martinsried/Munich, July 23, 2010.  MediGene AG (Frankfurt, Prime Standard, MDG,
TecDAX) announces that for organisational reasons the publication of the
6-month 2010 financial report has been rescheduled to Thursday, August 5, 2010
(previously: Friday, August 6, 2010).

An analyst conference call and webcast in English will take place at 10:00 am
CET on Thursday, August 5, 2010. Access to the webcast including synchronized
slides will be possible at the MediGene website at www.medigene.com. A replay
will also be available thereafter.



- ends -

MediGene AG is a publicly listed (Frankfurt, Prime Standard: MDG, TecDAX)
biotechnology company located in Martinsried/Munich, Germany, with subsidiaries
in Oxford, UK and San Diego, USA. MediGene is the first German biotech company
to have drugs on the market which are distributed by partner companies. It has
several drug candidates in clinical development and possesses innovative
platform technologies. MediGene focuses on clinical research and development of
novel drugs with focus on oncology.


Contact MediGene AG

Email: investor@medigene.com
Fax: ++49 - 89 - 85 65 - 2920
Julia Hofmann / Dr. Nadja Wolf, Public Relations, Tel.: ++49 - 89 - 85 65 - 3324
Dr. Georg Dönges, Investor Relations, Tel.: ++49 - 89 - 85 65 - 2946



[HUG#1433783]



--- End of Message ---

MediGene AG
Lochhamer Strasse 11 Martinsried / München Germany

WKN: 502090;ISIN: DE0005020903;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;





This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
All reproduction for further distribution is prohibited.

Source: MediGene AG via Thomson Reuters ONE
Related Links: Medigene AG
Author:
Hugin
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.